Integrated Quantitative Investments LLC Stoke Therapeutics, Inc. Transaction History
Integrated Quantitative Investments LLC
- $340 Billion
- Q2 2025
A detailed history of Integrated Quantitative Investments LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Integrated Quantitative Investments LLC holds 19,300 shares of STOK stock, worth $674,342. This represents 0.06% of its overall portfolio holdings.
Number of Shares
19,300Holding current value
$674,342% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding STOK
# of Institutions
138Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$189 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$189 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$179 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$162 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$153 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.38B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...